We're excited to host Adebayo, Co-founder & CEO of RxAll. We'll cover his founder journey, trends in innovation and deeptech, and the problem developing countries face that RxAll aims to solve.

Adebayo is a multi-award winning and renowned global pioneer of in-situ drug checking using deepTech in pharma. He co-founded RxAll in 2016 after working for 10 years with Sanofi, Roche, BASF, BCG in market development and strategy consulting. Through RxAll, he aims to provide a means for patients in the developing world to authenticate their medicines. His career in pharma is driven by a passion to eliminate fake drugs as he almost died as a child from a counterfeit medicine.

RxAll's AI nanoscanner called the RxScanner and cloud based algorithm helps regulators, narcotics control agencies, pharma manufacturers and hospitals ensure that all drugs sold are of the highest quality.